Health Catalyst

HCAT

Market cap $196M

Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement SALT LAKE CITY , Sept. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert has been appointed as President and Chief Operating Officer.

SALT LAKE CITY , Sept. 9, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a new partnership with CyncHealth Nebraska, the statewide health information exchange (HIE).

Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY , Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the winners of the 2025 Catalyst Awards, an annual program recognizing healthcare organizations at the forefront of data-driven transformation.   The Catalyst Awards were presented at the Health Catalyst Analytics Summit (HAS) 2025 in Salt Lake City, Utah.

Hospitals and Health Systems Can Now Benefit from a Validated Consumer Science Model and Proprietary Business Intelligence SALT LAKE CITY , Aug. 26, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Upfront by Health Catalyst ("Upfront") has launched Market Insights on Salesforce AppExchange, a leading enterprise marketplace for partner apps and experts. With Market Insights, clients can guide more patients to care using actionable consumer insights that drive content optimizations, power intelligent user journeys, and improve campaign performance.

SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:

Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Daniel LeSueur - Chief Operating Officer Daniel D. Burton - CEO & Director Jack Knight - Corporate Participant Jason Alger - Chief Financial Officer Conference Call Participants Daniel R.

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.12 per share a year ago.

Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search SALT LAKE CITY , Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst Chief Executive Officer Dan Burton is stepping down from his role as CEO, effective June 2026, to enable additional time to pursue a few volunteer service opportunities he and his wife will participate in, in support of their faith, as active members of the Church of Jesus Christ of Latter-Day Saints. As a result, Mr.

SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. “For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric.